Compare PEPG & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEPG | RGCO |
|---|---|---|
| Founded | 2018 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 229.4M |
| IPO Year | 2022 | 2005 |
| Metric | PEPG | RGCO |
|---|---|---|
| Price | $3.08 | $21.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $11.17 | ★ $22.70 |
| AVG Volume (30 Days) | ★ 1.0M | 13.3K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | ★ 25.61 | 11.21 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $95,334,212.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $2.89 |
| P/E Ratio | ★ N/A | $15.94 |
| Revenue Growth | N/A | ★ 12.63 |
| 52 Week Low | $1.17 | $20.55 |
| 52 Week High | $7.80 | $27.17 |
| Indicator | PEPG | RGCO |
|---|---|---|
| Relative Strength Index (RSI) | 59.32 | 45.65 |
| Support Level | $1.47 | $20.81 |
| Resistance Level | $3.14 | $22.80 |
| Average True Range (ATR) | 0.20 | 0.52 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 27.27 | 57.21 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.